JHSPersonal Care
JHS Svendgaard Laboratories Ltd — Profit & Loss Statement
₹6.55
-4.15%
JHS Svendgaard Laboratories Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | -0.86 Cr | 0.23 Cr | -4.39 Cr | 0.05 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.24 | 0.30 | — |
| Normalized EBITDA | -1.13 Cr | 2.58 Cr | 2.15 Cr | 8.27 Cr | — |
| Total Unusual Items | -2.86 Cr | 0.76 Cr | -18.58 Cr | 0.15 Cr | — |
| Total Unusual Items Excluding Goodwill | -2.86 Cr | 0.76 Cr | -18.58 Cr | 0.15 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.05 Cr | — |
| Reconciled Depreciation | 7.95 Cr | 6.35 Cr | 6.02 Cr | 7.05 Cr | — |
| Reconciled Cost Of Revenue | 61.04 Cr | 49.45 Cr | 67.54 Cr | 65.32 Cr | — |
| EBITDA | -3.99 Cr | 3.34 Cr | -16.43 Cr | 8.42 Cr | — |
| EBIT | -11.94 Cr | -3.00 Cr | -22.45 Cr | 1.37 Cr | — |
| Net Interest Income | -0.56 Cr | 0.10 Cr | 0.44 Cr | 0.81 Cr | — |
| Interest Expense | 0.56 Cr | 0.42 Cr | 0.50 Cr | 1.27 Cr | — |
| Normalized Income | -17.74 Cr | -4.59 Cr | -3.34 Cr | -4.16 Cr | — |
| Net Income From Continuing And Discontinued Operation | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.05 Cr | — |
| Total Expenses | 103.96 Cr | 76.07 Cr | 98.68 Cr | 90.52 Cr | — |
| Diluted Average Shares | 8.33 Cr | 7.80 Cr | 7.84 Cr | 6.45 Cr | — |
| Basic Average Shares | 8.33 Cr | 7.80 Cr | 7.84 Cr | 6.45 Cr | — |
| Diluted EPS | -2.37 | -0.52 | -2.23 | -0.63 | — |
| Basic EPS | -2.37 | -0.52 | -2.23 | -0.63 | — |
| Diluted NI Availto Com Stockholders | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.05 Cr | — |
| Net Income Common Stockholders | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.05 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.05 Cr | — |
| Minority Interests | 0.00 | 0.00 | 1.31 Cr | 0.24 Cr | — |
| Net Income Including Noncontrolling Interests | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.29 Cr | — |
| Net Income Continuous Operations | -19.74 Cr | -4.06 Cr | -17.52 Cr | -4.29 Cr | — |
| Tax Provision | 7.24 Cr | 0.63 Cr | -5.43 Cr | 4.39 Cr | — |
| Pretax Income | -12.51 Cr | -3.43 Cr | -22.95 Cr | 0.10 Cr | — |
| Other Non Operating Income Expenses | 2.88 Cr | 2.10 Cr | 8.89 Cr | 3.52 Cr | — |
| Special Income Charges | -2.86 Cr | 0.47 Cr | -18.65 Cr | 0.00 | — |
| Net Non Operating Interest Income Expense | -0.56 Cr | 0.10 Cr | 0.44 Cr | 0.81 Cr | — |
| Interest Expense Non Operating | 0.56 Cr | 0.42 Cr | 0.50 Cr | 1.27 Cr | — |
| Operating Income | -11.96 Cr | -6.27 Cr | -14.60 Cr | -5.03 Cr | — |
| Operating Expense | 42.92 Cr | 26.62 Cr | 31.15 Cr | 25.19 Cr | — |
| Other Operating Expenses | 24.85 Cr | 8.97 Cr | 8.38 Cr | 5.60 Cr | — |
| Depreciation And Amortization In Income Statement | 7.95 Cr | 6.35 Cr | 6.02 Cr | 7.05 Cr | — |
| Depreciation Income Statement | 7.95 Cr | 6.21 Cr | 6.00 Cr | 6.33 Cr | — |
| Gross Profit | 30.96 Cr | 20.36 Cr | 16.55 Cr | 20.17 Cr | — |
| Cost Of Revenue | 61.04 Cr | 49.45 Cr | 67.54 Cr | 65.32 Cr | — |
| Total Revenue | 92.00 Cr | 69.81 Cr | 84.08 Cr | 85.49 Cr | — |
| Operating Revenue | 92.00 Cr | 69.81 Cr | 84.08 Cr | 85.49 Cr | — |
| Interest Income | — | 0.56 Cr | 0.99 Cr | 2.20 Cr | 0.83 Cr |
| Rent Expense Supplemental | — | 0.27 Cr | 0.10 Cr | 20000.00 | 77000.00 |
| Other Special Charges | — | -0.70 Cr | 16.03 Cr | — | 0.05 Cr |
| Write Off | — | 0.22 Cr | 2.62 Cr | 0.00 | 3.29 Cr |
| Total Other Finance Cost | — | 0.04 Cr | 0.05 Cr | 0.12 Cr | — |
| Interest Income Non Operating | — | 0.56 Cr | 0.99 Cr | 2.20 Cr | 0.83 Cr |
| Amortization | — | 0.13 Cr | 0.01 Cr | 0.72 Cr | 0.02 Cr |
| Research And Development | — | 0.00 | 0.07 Cr | 0.07 Cr | 14000.00 |
| Selling General And Administration | — | 2.91 Cr | 7.26 Cr | 2.40 Cr | 2.45 Cr |
| Selling And Marketing Expense | — | 1.17 Cr | 2.76 Cr | 0.71 Cr | 0.69 Cr |
| General And Administrative Expense | — | 1.74 Cr | 4.50 Cr | 1.69 Cr | 1.76 Cr |
| Rent And Landing Fees | — | 0.27 Cr | 0.10 Cr | 20000.00 | 77000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on JHS Svendgaard Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.